This study is testing a new way to decide on chemotherapy treatment after surgery for colon cancer. After surgery, doctors will check for tiny bits of cancer DNA called circulating tumor DNA (ctDNA) in your blood. If you have no ctDNA, your risk of cancer returning is low, so you might not need more treatment. But if ctDNA is found, it means a higher risk of cancer returning, and different types of chemotherapy might be considered.
To join, you need to have had a certain type of colon cancer surgery and meet health requirements. You should not have cancer that has spread, other serious illnesses, or a history of certain other cancers.
- Study Length: Participation might last up to 6 months with follow-ups.
- Visits Needed: Regular check-ups and tests are required to monitor your blood for ctDNA.
- Compensation: Information about compensation is not provided, check with the study team.
How understandable was the trial content above?
Hard to understand
Easy to understand